Yuzhou D. Gan
Beijing, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 27 publications
Endothelial cell-derived plasminogen activator inhibitor-1 potentiates thrombosis in antiphospholipid syndrome.
Journal: Journal of autoimmunity
Published: January 19, 2026
Analysis of 12 Pathogens in surveillance cases of febrile respiratory syndrome in Daxing district of Beijing City from 2018 to 2023
Journal: Zhonghua yu fang yi xue za zhi [Chinese journal of preventive medicine]
Published: April 03, 2025
IL-2 detected by flow cytometry and its significance in systemic lupus erythematosus.
Journal: Clinical rheumatology
Published: November 21, 2024
Oxidised low-density lipoprotein and antibodies against oxidised low-density lipoprotein in patients with antiphospholipid syndrome.
Journal: Clinical and experimental rheumatology
Published: February 10, 2024
A diagnostic performance study of the 2023 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for patients with antiphospholipid syndrome from the Antiphospholipid Syndrome Chinese Collaborative cohort presenting with suspected antiphospholipid syndrome.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: January 22, 2024
Clinical and immunological characteristics and prognosis of patients with autoantibody negative dermatomyositis: a case control study.
Journal: Clinical rheumatology
Published: August 09, 2023
A GITRL-mTORC1-GM-CSF Positive Loop Promotes Pathogenic Th17 Response in Primary Sjögren Syndrome.
Journal: Arthritis & rheumatology (Hoboken, N.J.)
Published: June 14, 2023
Low dose versus standard dose rituximab for the treatment of antiphospholipid syndrome: A pilot study from a tertiary medical center.
Journal: Frontiers in immunology
Published: June 17, 2022
Dynamics of T follicular helper cells in patients with rheumatic diseases and subsequent antibody responses in a three-dose immunization regimen of CoronaVac.
Journal: Immunology
Published: June 08, 2022
Low Dose Interleukin-2 Ameliorates Sjögren's Syndrome in a Murine Model.
Journal: Frontiers in medicine
Published: March 01, 2022
Last Updated: 09/26/2026